← Back to all trials
Recruiting
NCT06982209
ANI-Guided Anesthetic Desflurane Consumption
Conditions: Postoperative Pain, General Anesthesia, Laparoscopic Cholecystectomy
Sex: All
Ages: 19 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 125
Sponsor: Wonkwang University Hospital
Location: Wonkwang University School of Medicine Hospital Iksan Jeollabuk-do
Summary
General anesthesia requires precise titration of inhaled anesthetics like desflurane and opioids like remifentanil to balance sedation, analgesia, and hemodynamic stability. The Analgesia/Nociception Index (ANI), derived from heart rate variability (HRV), quantifies parasympathetic tone to assess nociception-antinociception balance on a 0-100 scale, with lower values indicating nociceptive stress. ANI analyzes high-frequency HRV components, reflecting parasympathetic inhibition during painful stimuli, making it a reliable indicator of intraoperative nociception. Studies validate the utility of ANI in detecting nociceptive events during laparoscopic surgery. ANI-guided opioid titration reduces opioid consumption and stabilizes hemodynamics, enhancing perioperative outcomes.
Eligibility Criteria
Inclusion Criteria:
* aged 19-65 years, American Society of Anesthesiologists (ASA) physical status I-II, scheduled for elective laparoscopic cholecystectomy under general anesthesia.
Exclusion Criteria:
* chronic pain, preoperative opioid use, cardiac arrhythmias, autonomic dysfunction, or contraindications to desflurane or remifentanil.
Source: ClinicalTrials.gov (NCT06982209). StuddyBuddy aggregates publicly available trial information.